How Shadowbox evolved it’s ICP from desperate labs to health systems with 500-1,000 community providers | Gregory Stein

Healthcare providers waste $950 billion annually on manual workarounds caused by fragmented EHR systems and integration costs that don't scale. Shadowbox has developed a patented browser technology that functions as an API, enabling instant EHR data access without traditional integration expenses. In this episode of Category Visionaries, we sat down with Gregory Stein, CEO of Shadowbox, to dissect how the company evolved from serving desperate lab diagnostics customers to building strategic partnerships with established healthcare IT players like HC1 to reach health systems.

Topics Discussed:

• How the 21st Century Cures Act information blocking provisions remain largely unenforced, allowing EHR vendors to maintain data monopolies through integration fees
• Shadowbox's technical architecture: a white-labeled browser that accesses the document object model and API endpoints to extract HIPAA-compliant data without custom integrations
• Market entry strategy—targeting financially distressed lab diagnostics providers who couldn't afford traditional integration costs
• The HC1 partnership model: splitting the market by use case rather than geography, with HL7/API integrations going to HC1 and rapid, low-cost deployments going to Shadowbox
• Sequential interoperability capabilities that enable multiple vendor touchpoints (prior authorization, eligibility verification, billing) from a single data extraction

GTM Lessons For B2B Founders:

• Target customers facing existential financial pressure, not optimal market conditions: Shadowbox entered through lab diagnostics—a commoditized, low-margin segment hemorrhaging money where providers faced $5K-$50K integration costs per connection taking 3-6 months. Greg acknowledged labs are "the redheaded stepchild of healthcare" but their desperation made them willing to pilot unproven technology. The lesson: segments with severe unit economics problems become early adopter pools because status quo costs exceed perceived risk of new vendors.
• Build a partnerships function before you have market leverage: Shadowbox hired a partnerships-focused employee early to cultivate relationships with RCM vendors and lab information system providers already selling to target customers. Rather than waiting for customer traction to attract partners, they used partnerships to generate initial traction. Greg emphasized healthcare adoption requires credible references—partnerships provide instant credibility entrepreneurs can't buy. Map your ecosystem's existing vendor relationships and pursue co-sell arrangements before achieving meaningful ARR.
• Use early customer feedback to migrate upmarket, not pivot laterally: Shadowbox started with labs, expanded to imaging centers, but their true ICP emerged as health systems with 500-1,000 community providers on disparate EHRs where traditional integration economics break down. Greg noted: "health systems that have major outreach programs where it doesn't pencil out to have them on their EPIC system." The migration path moved from small, desperate customers toward larger organizations facing the same core problem at scale. Don't mistake initial ICP for ultimate ICP—use early segments as beachheads to validate technology before pursuing customers with better economics.
• Partner with horizontal competitors when you solve orthogonal use cases: The HC1 deal splits the interoperability market—structured, predictable integrations go to HC1's traditional approach while rapid deployments to fragmented provider networks go to Shadowbox. This isn't channel partnership but market segmentation by use case economics. Greg explained they bring "something complementary to and in some ways competitive" but combined create offerings competitors can't match. Evaluate whether your "competitors" actually serve different jobs-to-be-done within the same category, then structure partnerships around use case delineation rather than territorial splits.
• Leverage policy expertise as product moat in regulated markets: Greg's Capitol Hill background enabled Shadowbox to support the Coalition for Innovative Lab Testing's successful lawsuit blocking FDA regulation of lab-developed tests—directly protecting their customers' business models. This wasn't marketing but strategic positioning that demonstrates commitment beyond vendor relationships. In heavily regulated industries, founders with policy expertise or advisors who can shape regulatory outcomes create defensibility that pure technology cannot. Consider how industry advocacy amplifies customer loyalty while potentially expanding TAM through favorable regulatory changes.

//

Sponsors:

Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io

The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe. www.GlobalTalent.co

//

Don't Miss: New Podcast Series — How I Hire

Senior GTM leaders share the tactical hiring frameworks they use to build winning revenue teams. Hosted by Andy Mowat, who scaled 4 unicorns from $10M to $100M+ ARR and launched Whispered to help executives find their next role.

Subscribe here: https://open.spotify.com/show/53yCHlPfLSMFimtv0riPyM